Advertisement
Home 2016

Archives

Suicide rates in the United States rose 24 percent between 1999 and 2014

CDC: Suicide Rate Up 24 Percent in the United States Since 1999

0
Rates climbed the most among middle-aged men and girls aged 10 to 14
Summer

CDC, OSHA Issue Guidance on Occupational Exposure to Zika

0
One advisory: Don't make travel to endemic areas mandatory for employees
Alcohol

Stomach CA Risk Up With Alcohol, Processed Meat Consumption

0
Excess weight also seems to increase chances of disease, and risk increases as three factors increase
A cluster of rare bloodstream infections was discovered by Illinois health officials while investigating an outbreak in Wisconsin.

Ten Cases of Rare Bloodstream Infection Reported in Illinois

0
Cases of infection from the bacterium Elizabethkingia included six deaths
The U.S. Centers for Disease Control and Prevention has referred to Zika virus as causing microcephaly and other birth defects

ACOG Responds to CDC Update on Zika Causing Microcephaly

0
Recommendations on prevention and avoiding Zika remain in place after CDC update on Zika
Zika virus is a definite and direct cause of microcephaly and other brain-related birth defects

CDC: Zika Link to Microcephaly, Brain Damage Confirmed

0
Evidence confirms infection during early pregnancy leads to severe form of microcephaly
Makers of corn masa flour can voluntarily add up to 0.7 mg of folic acid per pound of corn masa flour under a new approval by the U.S. Food and Drug Administration.

FDA: Makers of Corn Masa Flour Can Fortify With Folic Acid

0
Corn masa is a staple for many Latinos; may help prevent neural tube birth defects
U.S. hospital procedures and questionnaires used to manage patient pain lead to overprescribing of addictive opioids and need to be changed

Coalition Calls for Changes to Hospital Pain Assessments

0
Petition asks government to release proposal for a new pain questionnaire for hospital patients
There has been an increase in the number of patients being treated for Galactose-alpha-1

Increase in Number of Patients Being Treated for Alpha-Gal

0
Increase attributed to improved understanding of presentation, and improved diagnostic testing
Venclexta (venetoclax) has been approved by the U.S. Food and Drug Administration to treat chronic lymphocytic leukemia characterized by a specific chromosomal abnormality

FDA Approves Venclexta for CLL With 17p Deletion

0
Drug sanctioned for chronic lymphocytic leukemia in patients with a specific chromosomal abnormality